<DOC>
	<DOCNO>NCT02777476</DOCNO>
	<brief_summary>This post-marketing study B-Lite® implant carry EC certificate marketing Europe AMAR certificate marketing Israel . To date , hundred implant already implanted woman . The study open primary augmentation patient . All surgery perform per standard practice give study site . No parallel surgical procedure perform session .</brief_summary>
	<brief_title>Clinical Performance B-Lite® Light Weight Breast Implant</brief_title>
	<detailed_description />
	<criteria>Genetic woman age 18 60 seek primary breast augmentation Patient eligible undergo MRI ( i.e. , implant metal metal device , history severe claustrophobia ) Patient provide sign informed consent Patient agree comply study protocol complete require follow visit , include undergo MRI Patient agree return device Sponsor implant explanted The patient realistic expectation surgical result discussion investigator acceptable candidate breast augmentation . Patients active infection anywhere body Patient pregnant nursing time recruitment , 6 month precede recruitment date , willing use reliable mean contraception first year surgery Patient implant silicone implant breast implant ( e.g. , silicone artificial joint facial implant ) Patient breast tissue clinically incompatible procedure ( e.g. , tissue damage result radiation , insufficient tissue coverage compromise vascularity ) Patient condition , treatment condition , , opinion investigator and/or consult physician ( ) , may constitute unwarranted surgical risk ( e.g. , unstable cardiac pulmonary problem , possible allergy and/or extraordinary immune response implant ) The patient history mental instability and/or history pharmaceutical psychiatric treatment Patient unable understand scope study and/or surgery The patient disease , include uncontrolled diabetes ( e.g. , HbA1c &gt; 8 % ) , clinically know impact wound heal ability Patient exist costal injury Patient abscess , malignant tumor ( cancer recurrent metastasis ) , clinically relevant cyst advance fibrotic disease patient BIRAD ≥3 Are willing undergo surgery revision , medically require The patient confirm rheumatic disease syndrome ( e.g. , SLE , Sjogren 's syndrome , scleroderma , polymyositis connective tissue disorder , rheumatoid arthritis , crystalline arthritis , infectious arthritis , spondyloarthropathies , inflammatory arthritis , fibromyalgia chronic fatigue syndrome ) The patient severe breast upper trunk deformity The patient participate investigational trial within 90 day enrollment The patient undergone invasive medical procedure within 90 day enrollment . Aesthetic addiction , drug abuse , alcohol abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>